Valuation: Strides Pharma Science Limited

Market Cap 99.08B 1.03B 899M 830M 765M 1.44B 1.47B 9.92B 3.9B 48.52B 3.86B 3.78B 167B P/E 2026
15.5x
P/E 2027 * 15.8x
Enterprise Value 99.08B 1.03B 899M 830M 765M 1.44B 1.47B 9.92B 3.9B 48.52B 3.86B 3.78B 167B EV / Sales 2026
1.78x
EV / Sales 2027 * 1.7x
Free-Float
68.07%
Yield 2026
0.53%
Yield 2027 * 0.28%
1 day+2.57%
1 week-0.36%
Current month-1.40%
1 month-2.99%
3 months+7.71%
6 months+19.68%
Current year+19.45%
1 week 1,008.5
Extreme 1008.5
1,100
1 month 1,008.5
Extreme 1008.5
1,149.4
Current year 769.6
Extreme 769.6
1,231.45
1 year 769.6
Extreme 769.6
1,231.45
3 years 412.45
Extreme 412.45
1,675.25
5 years 263.45
Extreme 263.45
1,675.25
10 years 263.45
Extreme 263.45
1,675.25
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member 82 18/05/2017
Director/Board Member 58 11/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.57%-0.36% - - 1.03B
-0.90%-0.15%+14.11%+81.10% 48.15B
-0.23%-1.65%+67.15%+112.03% 35.59B
-0.76%-1.44%-4.29%+37.63% 11.9B
-0.88%-0.62%+17.31%+89.97% 11.85B
+0.19%+2.87%+34.92%+139.73% 9.31B
+3.37%-0.10%+51.64%-3.75% 7.02B
-0.75%-0.91%+17.45%+37.70% 6.91B
-2.25%-2.08%+0.45%+209.99% 6.55B
-9.93%+0.35%-31.51%+16.58% 6.13B
Average -0.96%+0.06%+18.58%+80.11% 15.93B
Weighted average by Cap. -0.86%-0.42%+26.79%+86.59%

Financials

2026 2027 *
Net sales 48.28B 501M 438M 404M 373M 702M 718M 4.83B 1.9B 23.65B 1.88B 1.84B 81.4B 58.23B 605M 528M 488M 449M 847M 866M 5.83B 2.29B 28.52B 2.27B 2.22B 98.17B
Net income 5.74B 59.57M 52.06M 48.04M 44.28M 83.46M 85.31M 574M 226M 2.81B 224M 219M 9.67B 6.28B 65.18M 56.96M 52.57M 48.45M 91.32M 93.35M 628M 247M 3.07B 245M 239M 10.58B
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,301
Date Price Change Volume
17/07/26 INR 1,077.90 +2.57% 14,873
16/07/26 INR 1,050.90 -1.07% 4,883
15/07/26 INR 1,062.30 -0.67% 2,890
14/07/26 INR 1,069.50 -0.50% 5,430
13/07/26 INR 1,074.85 -0.64% 3,534
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,074.90INR
Average target price
1,338.67INR
Spread / Average Target
+24.54%

Quarterly revenue - Rate of surprise